Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Isosorbide Mononitrate Tablet Market Growth in 2025?

The market for isosorbide mononitrate tablets has seen robust growth in the past few years. The market’s value, which was $1.14 billion in 2024, is projected to rise to $1.21 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%. Several factors can explain this growth during the historic period, such as the rising elderly population, increased prevalence of heart diseases, heightened awareness about heart health, availability of generic drugs, and public health initiatives.

What Is the Forecast for the Isosorbide Mononitrate Tablet Market Size Through 2029?

The market for isosorbide mononitrate tablets is predicted to exhibit significant growth in the coming years, with an estimated valuation of $1.51 billion by 2029, expanding at a CAGR of 5.6%. The acceleration during the forecast period could be due to factors such as regulatory sanctions and patent expiries, growing usage of generic medications, a rise in lifestyle-associated risk elements, government-led initiatives towards cardiovascular disease control, enhancements in diagnostic facilities, and awareness initiatives. Key trends during this forecast period encompass developments in extended-release formulations, technological novelties, e-commerce and digital health platforms, utilization of digital health tech and the blend of isosorbide mononitrate with alternate cardiovascular drugs.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24268&type=smp

What are the Key Market Players in Isosorbide Mononitrate Tablet Market and How They’re Evolving?

Major companies operating in the isosorbide mononitrate tablet market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, Abbott Laboratories Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Zydus Lifesciences Limited, Recipeharm, Torrent Pharmaceuticals Ltd., Micro Labs Ltd., Lotus Pharmaceuticals, Healthy Inc., Qilu Pharmaceutical Co., Ltd, Lunan Pharmaceutical Group, Johnlee Pharmaceuticals Pvt. Ltd., Niksan Pharmaceutical, Shandong Keyuan Pharmaceutical, Prevego Healthcare & Research Private Limited.

What Are the Primary Growth Drivers in the Isosorbide Mononitrate Tablet Market?

The escalating incidence of cardiovascular diseases is anticipated to spur the expansion of the isosorbide mononitrate tablet market. Such diseases, which include coronary artery disease, heart failure and hypertension, manifest in the heart and blood vessels. The surge in cardiovascular diseases is largely due to unhealthy food habits filled with saturated and trans fats, sodium and added sugars, resulting in ailments such as obesity, hypertension, and high cholesterol. Isosorbide mononitrate tablets aid in managing these conditions with their ability to relax and widen blood vessels, thereby improving blood circulation, cutting down the heart’s workload, and boosting oxygen supply to the heart. For instance, as per the Australian Institute of Health and Welfare’s data from December 2023, deaths from coronary heart disease saw an increase from 14,100 in 2021 to a further rise to 14,900 in 2022. It underscores the reason that escalating trend of cardiovascular diseases is contributing to the growing isosorbide mononitrate tablet market. An upswing in online pharmacies is also supporting the market growth, owing to a rising customer requirement for comfort and easy accessibility. Online pharmacies are digital gateways permitting consumers to buy prescription and over-the-counter drugs over the internet. Factors like consumer’s search for convenience, cost-effectiveness, and simpler access to medications and healthcare items without needing to visit physical stores are leading to an increase in online pharmacies. Such pharmacies enable easy access to isosorbide mononitrate tablets by offering home delivery, competitive rates, and enhanced availability, particularly beneficial for patients with chronic ailments. For instance, a survey by the Alliance for Safe Online Pharmacies (ASOP) in September 2023, on 1,500 Americans, shows a 10% increase from 2021 and a 17% rise from 2020 in the use of online pharmacies by 52% of Americans aged 18 and above. Consequently, the growth in online pharmacies is propelling the expansion of the isosorbide mononitrate tablet market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24268&type=smp

What Are the Leading Segments in the Global Isosorbide Mononitrate Tablet Industry?

The isosorbide mononitrate tablet market covered in this report is segmented –

1) By Dosage Form: Immediate-Release Tablets, Extended-Release Tablets

2) By Indication Type: Angina Pectoris, Heart Failure, Hypertension

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Immediate-Release Tablets: Low-Dose, Single Strength Tablets, Combination With Other Drugs

2) By Extended-Release Tablets: Moderate-Dose, High-Dose, Once-Daily Formulation, Twice-Daily Formulation

What Are the Key Market Trends in the Isosorbide Mononitrate Tablet Industry?

Prominent firms in the isosorbide mononitrate tablet industry are centering their efforts on creating groundbreaking products such as extended-release (ER) versions to improve patient adherence, offer continuous therapeutic impacts, and refine treatment results for disorders like angina pectoris. The ER formulation is a cutting-edge drug delivery system that permits the slow release of medicine over an extended time, reducing the frequency of dosage and maintaining stable levels of the drug in the blood. For example, in February 2024, Zydus Lifesciences Limited, a pharmaceutical manufacturing company based in India, obtained approval from the United States Food and Drug Administration (USFDA) to produce and distribute isosorbide mononitrate ER tablets USP in the strengths of 30 mg, 60 mg, and 120 mg. These tablets, which are used to circumvent chest pain (angina) in patients suffering from coronary artery disease, match the reference listed drug (RLD), Imdur extended-release tablets.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/isosorbide-mononitrate-tablet-global-market-report

What Is the Regional Outlook for the Isosorbide Mononitrate Tablet Market?

North America was the largest region in the isosorbide mononitrate tablet market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the isosorbide mononitrate tablet market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/customise?id=24268&type=smp

This Report Delivers Insight On:

1. How big is the isosorbide mononitrate tablet market, and how is it changing globally?

2. Who are the major companies in the isosorbide mononitrate tablet market, and how are they performing?

3. What are the key opportunities and risks in the isosorbide mononitrate tablet market right now?

4. Which products or customer segments are growing the most in the isosorbide mononitrate tablet market?

5. What factors are helping or slowing down the growth of the isosorbide mononitrate tablet market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model